XRN 10-K & 10-Q changes, risk factors and insider trading
Chiron Real Estate Inc. (also XRN-PA, XRN-PB) · NYSE · Real Estate Investment Trusts · CIK 1533615 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Our property development joint venture (See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Recent Developments― Inaugural Active Adult Investment,”) and future development joint ventures, property redevelopment and tenant improvement risks can render a project less profitable or unprofitable and delay or prevent its undertaking or completion.”
Removed heading “Healthcare wage inflation increased dramatically due to the COVID-19 virus and remained elevated throughout 2024, which has in the past and could continue to materially and adversely affect certain of our tenants’ businesses. Other viruses or pandemics could cause similar effects to healthcare wage inflation in the future.”
Removed heading “An epidemic or pandemic (such as the outbreak and worldwide spread of COVID-19), and the measures that international, federal, state and local governments, agencies, law enforcement and/or health authorities implement to address it, may precipitate or materially exacerbate one or more of our other risks, and may significantly disrupt our business.”
Removed heading “Interest rate swaps related to our $350 million term loan (“Term Loan A”) are set to expire in April 2026. If we enter into new interest rate swaps to hedge the interest rate risk related to Term Loan A, the swap rate for any new interest rate swaps may be significantly higher than our current swaps, which could cause a material increase in our borrowing costs, which could, among other things, increase our cost of capital and decrease our earnings, liquidity, cash available to make distributions to our stockholders and the trading price of our common and preferred stock.”
Removed heading “We are subject to risks related to corporate social responsibility.”
Largest changes
“Interest rate swaps related to our $350 million term loan (“Term Loan A”) are set to expire in April 2026. If we enter into new interest rate swaps to hedge the interest rate risk related to Term Loan A, the swap rate for any new interest rate swaps may be significantly higher than our current swaps, which could cause a material increase in our borrowing costs, which could, among other things, increase our cost of capital and decrease our earnings, liquidity, cash available to make distributions to our stockholders and the trading price of our common and preferred stock.”see in full comparison
“Healthcare wage inflation increased dramatically due to the COVID-19 virus and remained elevated throughout 2024, which has in the past and could continue to materially and adversely affect certain of our tenants’ businesses. Other viruses or pandemics could cause similar effects to healthcare wage inflation in the future.”see in full comparison
“An epidemic or pandemic (such as the outbreak and worldwide spread of COVID-19), and the measures that international, federal, state and local governments, agencies, law enforcement and/or health authorities implement to address it, may precipitate or materially exacerbate one or more of our other risks, and may significantly disrupt our business.”see in full comparison
“The COVID-19 epidemic caused a dramatic increase in healthcare wage inflation, as the supply of U.S. healthcare workers, especially nurses, decreased due to, among other reasons, nurses experiencing burnout due to the length and severity of the pandemic. Healthcare wage inflation has yet to return to pre-pandemic levels and these wage increases have materially and adversely affected the businesses of many healthcare operators, especially hospital systems, which rely heavily on nurses. …”see in full comparison
“In April 2026, interest rate swaps related to our Term Loan A are set to expire in connection with the maturity of Term Loan A. The swap rate with respect to our current interest rate swaps related to our Term Loan A is 1.36%. As of December 31, 2024, the five-year forward SOFR swap rate, which is the swap rate that would most likely be used if we entered into new interest rate swaps in connection with an extension or refinancing of Term Loan A, was 3.97%. …”see in full comparison
“On May 6, 2024, our tenant, Steward Health Care (“Steward”), filed for Chapter 11 bankruptcy reorganization. In connection with the Steward bankruptcy, Steward rejected its largest lease with us at our healthcare facility in Beaumont, Texas (the “Beaumont Facility”). As of December 31, 2024, the Steward bankruptcy was still ongoing and Steward owed us $0.8 million in rent and $1.6 million in other amounts due in connection with the lease at the Beaumont Facility, which lease was rejected by Steward in connection with the bankruptcy. …”see in full comparison
Full comparison: every changed paragraph (40)
The inability of any of our significant tenants to pay rent to us could have a disproportionate negative affecteffect on our business.
Healthcare wage inflation increased dramatically due to the COVID-19 virus and remained elevated throughout 2024, which has in the past and could continue to materially and adversely affect certain of our tenants’ businesses. Other viruses or pandemics could cause similar effects to healthcare wage inflation in the future.
The COVID-19 epidemic caused a dramatic increase in healthcare wage inflation, as the supply of U.S. healthcare workers, especially nurses, decreased due to, among other reasons, nurses experiencing burnout due to the length and severity of the pandemic. Healthcare wage inflation has yet to return to pre-pandemic levels and these wage increases have materially and adversely affected the businesses of many healthcare operators, especially hospital systems, which rely heavily on nurses. If these labor costs remain elevated, healthcare practices, including our tenants, may continue to experience increased labor costs, which could negatively impact their businesses and their ability to pay rents to us. Additionally, the volatility of COVID-19, its variants and its subvariants are unpredictable and there are no assurances that new variants and subvariants will not emerge in the future. Other viruses or pandemics could also cause similar effects in the future.
An epidemic or pandemic (such as the outbreak and worldwide spread of COVID-19), and the measures that international, federal, state and local governments, agencies, law enforcement and/or health authorities implement to address it, may precipitate or materially exacerbate one or more of our other risks, and may significantly disrupt our business.
An epidemic or pandemic could have a material and adverse effect on or cause disruption to our business, financial condition, results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock due to, among other factors:
Our revenues are generated by our leases, which are typically medium-to-long-term leases with fixed rental rates, subject to annual rent escalators. The unhedged portion of our debt under our Third Amended and Restated Credit Facility debt(the “Credit Facility”) is subject to SOFR,the secured overnight financing rate (“SOFR”), which has increased substantially sincebeginning in early 2022 and remained elevated through the first half of 2025, before beginning to decline during 2024.the second half of 2025. The generally fixed nature of revenues and the variable rate of our debt obligations create interest rate risk for us. Increases in interest rates have not been matched by increases in our rental income, which has increased our expenses and has materially, adversely affected our business, financial condition, results of operations and the trading price of our common and preferred stock. Further increases in interest rates may exacerbate the aforementioned effects and have a material, adverse effect on our ability to make distributions to our stockholders.
On May 6, 2024, our former tenant, Steward Health Care (“Steward”), filed for Chapter 11 bankruptcy reorganization. As of December 31, 2025, the Steward bankruptcy was still ongoing and Steward owed us $1.7 million in pre-petition rent and other amounts, of which we have a general, unsecured claim.
On May 6, 2024, our tenant, Steward Health Care (“Steward”), filed for Chapter 11 bankruptcy reorganization. In connection with the Steward bankruptcy, Steward rejected its largest lease with us at our healthcare facility in Beaumont, Texas (the “Beaumont Facility”). As of December 31, 2024, the Steward bankruptcy was still ongoing and Steward owed us $0.8 million in rent and $1.6 million in other amounts due in connection with the lease at the Beaumont Facility, which lease was rejected by Steward in connection with the bankruptcy. Of the $2.4 million owed to us, approximately $1.7 million related to pre-petition claims, of which we have a general, unsecured claim, and $0.7 million related to post-petition, administrative claims, of which we have a priority claim. Although we have a priority claim with respect to $0.7 million, we may only receive a fraction, or may not receive any, of these amounts or amounts to which we have a general, unsecured claim if there are not enough assets in the bankruptcy estate to satisfy these claims.
On January 11, 2025, our tenant, Prospect Medical Group (“Prospect”), filed for Chapter 11 bankruptcy reorganization. As of JanuaryDecember 11,31, 2025, the Prospect bankruptcy was still ongoing and Prospect owed us approximately $2.4$0.2 million related to leases at three of our healthcare facilities, including $2.2 million related to our facility in Eastpre-and Orange,post-petition Newrents Jersey.and other amounts. As of February 26,20, 2025,2026, Prospect had notfiled yeta decidednotice ifof itlease wasrejection goingwith respect to acceptits or reject itsremaining leases with us. If ProspectProspect’s rejects anynotice of itslease leasesrejection withis us,approved by the court, we would have a general unsecured claim with respect to amounts owed under any rejected lease.
In January 2026, one of our tenants, White Rock Medical Center, LLC (“White Rock”) filed for Chapter 11 bankruptcy protection. See “Part II, Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations—Recent Developments—Chapter 11 Reorganization Filing of White Rock Medical Center, LLC,” for a description of the White Rock bankruptcy.
We may only receive a fraction, or may not receive any, of amounts owed to us by Stewart, Prospect and White Rock if there are not enough assets in each bankruptcy estate to satisfy these claims.
We have significant geographic concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, Arizona, and Michigan.Illinois. Economic and other conditions that negatively affect those states and our tenants in those states could have a greater effect on our revenues than if our properties were more geographically diverse.
As of December 31, 2024,2025, approximately 16%,17.0%, 12%,10.9%, 9%,8.0%, 7%,7.4%, 6%, 6%,6.5%, and 5%5.1% of our total annualized base rent was derived from properties located in Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, Arizona and Michigan,Illinois, respectively. As a result of this geographic concentration, we are particularly exposed to downturns in these states’ economies or other changes in local real estate market conditions. Any material changes in the current payment programs or regulatory, economic, environmental or competitive conditions in these states could have an amplified effect on our business, financial condition and results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock than if our properties were more geographically diverse.
OnAs Decemberof February 20, 2024,2026, we enteredhave into atwo joint venture to purchase two healthcare facilities,ventures, and we may enter into other joint ventures in the future. Our participation in joint ventures is subject to risks that may not be present with other methods of ownership, including:
In addition, in some instances, our joint venture partnerpartners will have the right to cause us to sell our interest, or acquire their interest, at a time when we otherwise would not have initiated such a transaction. Our ability to acquire our partner’s interest will be limited if we lack sufficient capital resources. This could require us to sell our interest in the joint venture when we might otherwise prefer to retain it. Any of the foregoing risks could materially adversely affect our business, financial condition, results of operations, our ability to pay distributions to our stockholders and the trading price of our common and preferred stock.
Our property development joint venture (See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Recent Developments― Inaugural Active Adult Investment,”) and future development joint ventures, property redevelopment and tenant improvement risks can render a project less profitable or unprofitable and delay or prevent its undertaking or completion.
Our property development joint venture, and future development joint ventures, redevelopment and tenant improvement projects could be canceled, abandoned, delayed or, if the development project is completed, fail to perform in accordance with expectations due to, among other things:
Project costs may materially exceed original estimates due to, among other things:
Delays in project completion also delay the commencement of related rental payments, including increases in rental payments following tenant improvement projects, and may provide tenants the right to terminate leases or cause us to incur additional costs, including through rent abatement.
Demand for a project may decrease prior to a project’s completion, and resulting lease-up rates, rental rates, lease commencement dates, and occupancy levels may fail to meet expectations. Tenants that have pre-leased at a project may file for bankruptcy or become insolvent, or elect to terminate their lease prior to delivery if they are acquired or for other reasons. Finally, a project may have defects that we do not discover through the inspection processes, including latent defects not discovered until after we put a property in service.
The foregoing risks could result in not achieving anticipated returns on investment and could materially adversely affect our business, financial condition, results of operations, our ability to pay distributions to our stockholders and the trading price of our common and preferred stock.
As of December 31, 2024,2025, we had seven12 buildings located on land that is subject to operating ground leases, representing approximately 4.5%9.6% of our December 20242025 annualized base rent. These ground leases contain certain restrictions. These restrictions include limits on our ability to re-let the facilities, rights of purchase and rights of first offer and refusal with respect to sales of the healthcare facility and limits on the types of medical procedures that may be performed at the facilities. These restrictions could affect our returns on these facilities which, in turn, could materially adversely affect our business, financial condition and results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock.
Interest rate swaps related to our $350 million term loan (“Term Loan A”) are set to expire in April 2026. If we enter into new interest rate swaps to hedge the interest rate risk related to Term Loan A, the swap rate for any new interest rate swaps may be significantly higher than our current swaps, which could cause a material increase in our borrowing costs, which could, among other things, increase our cost of capital and decrease our earnings, liquidity, cash available to make distributions to our stockholders and the trading price of our common and preferred stock.
In April 2026, interest rate swaps related to our Term Loan A are set to expire in connection with the maturity of Term Loan A. The swap rate with respect to our current interest rate swaps related to our Term Loan A is 1.36%. As of December 31, 2024, the five-year forward SOFR swap rate, which is the swap rate that would most likely be used if we entered into new interest rate swaps in connection with an extension or refinancing of Term Loan A, was 3.97%. Although our current swaps related to our Term Loan A will not expire until April 2026, we do not anticipate forward SOFR rates to return to the levels of our current swap rate and such rates may increase from the December 31, 2024 rates. If we enter into new interest rate swaps in connection with an extension or refinancing of Term Loan A, our borrowing costs could materially increase, which could, among other things, increase our cost of capital and decrease our earnings, liquidity, cash available to make distributions to our stockholders and the trading price of our common and preferred stock.
We use derivative instruments to hedge exposure to changes in interest rates on certain of our variable rate loans. As of December 31, 2024,2025, we had nine16 interest rate swap agreements (including forward-starting interest rate swaps) with a total notional amount of $500 million that fixed the SOFR component of the interest rate on oureach Term Loan A andof the $150 million term loan componentcomponents under our Credit Facility (“Term Loan B,” and, together with Term Loan A, the “Term Loans”).Facility. There is no assurance that our hedging instruments will adequately mitigate our interest rate risk or that our hedging strategy will not result in losses. Additionally, a hedging counterparty may fail to honor its obligations to us. If our interest rate hedges are unsuccessful in mitigating our interest rate risk, or if a hedging counterparty fails to honor its obligations to us, our borrowing costs would increase, which could, among other things, increase our cost of capital and decrease our earnings, liquidity, cash available to make distributions to our stockholders and the trading price of our common and preferred stock.
As of December 31, 2024,2025, we had $646.1$653.9 million of indebtedness outstanding (net of unamortized debt issuance costs). We may also place indebtedness on our healthcare facilities in the future. We run the risk of being unable to refinance such debt (including our Credit Facility debt, portions of which are set to mature during 2026) when the loans come due or of being unable to refinance on favorable terms. If interest rates are higher when we refinance debt, our income could be reduced. We may be unable to refinance debt at appropriate times, which may require us to sell healthcare facilities on terms that are not advantageous to us or could result in the foreclosure of such healthcare facilities. Any of these events could have a material adverse effect on our business, financial condition, results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock.
Sources of revenue for our tenants typically include the U.S. federal Medicare program, state Medicaid programs and private insurance payors. Healthcare providers continue to face increased government and private payor pressure to control or reduce healthcare costs and significant reductions in healthcare reimbursement, including reduced reimbursements and changes to payment methodologies under the Affordable Care Act. Beginning on January 1, 2026, premium tax credits that were intended to assist certain participants in purchasing health insurance expired, which could result in significant premium increases for these participants. In Janaury 2026, CMS announced proposed rate increases for 2027 to Medicare Advantage health plans of less than a tenth of a percent, which was less than market expectations. If finalized, this modest rate increase could result in benefit cuts or higher premiums for Medicare Advantage participants. In some cases, private insurers rely on all or portions of the Medicare payment systems to determine payment rates, which may result in decreased reimbursement from private insurers. Any reductions in payments or reimbursements from third-party payors could adversely affect the reimbursement rates received by our tenants, the financial success of our tenants and strategic partners and, therefore, our business, financial condition and results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock.
We periodically evaluate our real estate investments and other assets for impairment indicators. The judgment regarding the existence of impairment indicators is based upon factors such as market conditions, lease re-negotiations, tenant performance and legal structure. For example, the termination of a lease by a major tenant or an agreement to sell a property at a price below its book value may lead to an impairment charge. If we determine that an impairment has occurred, we would be required to make an adjustment to the net carrying value of the asset which could have a material adverse effect on our business, financial condition, results of operations and the trading price of our common and preferred stock. During the fourthyear quarterended ofDecember 2024,31, 2025, we incurred an impairment chargecharges of $1.7$13.0 million inrelated connectionto with onetwo of our healthcare facilities.
Any future distributions will be at the sole discretion of the Board and will depend upon a number of factors, including our actual and projected results of operations, the cash flow generated by our operations, funds from operationsoperations, Core FFO (“FFO”),formerly adjusted FFO (“AFFO”), funds available for distribution, liquidity, our operating expenses, our debt service requirements, capital expenditure requirements for the properties in our portfolio, prohibitions and other limitations under our financing arrangements, our REIT taxable income, the annual REIT distribution requirements, restrictions on making distributions under Maryland law and such other factors as the Board deems relevant. We cannot assure you that our distribution policy will not change in the future or that the Board will continue to declare dividends at the same rate as in 2024.2025.
For us to qualify as a REIT, no more than 50% of the value of our outstanding shares of stock may be owned, beneficially or constructively, by five or fewer individuals at any time during the last half of each taxable year other than our initial REIT taxable year.
For us to qualify as a REIT, no more than 50% of the value of our outstanding shares of stock may be owned, beneficially or constructively, by five or fewer individuals at any time during the last half of each taxable year other than our initial REIT taxable year. Subject to certain exceptions, our charter prohibits any stockholder from owning actually or constructively more than 9.8% in value or number of shares, whichever is more restrictive, of any class or series of our outstanding shares. The constructive ownership rules under the Internal Revenue Code of 1986, as amended (the “Code”), are complex and may cause the outstanding shares owned by a group of related individuals or entities to be deemed to be constructively owned by one individual or entity. As a result, the acquisition of less than 9.8% of our outstanding shares of any class or series by an individual or entity could cause that individual or entity to own constructively in excess of 9.8% of any class or series of our outstanding beneficial interests and to be subject to our charter’s ownership limit. Our charter also prohibits any person from owning shares of our beneficial interests that would result in our being “closely held” under Section 856(h) of the Code or otherwise cause us to fail to qualify as a REIT. Any attempt to own or transfer shares of our beneficial interest in violation of these restrictions may result in the shares being automatically transferred to a charitable trust or may be void.
Our success depends to a significant degree upon our executive officers and other key personnel. We rely on the services of JeffreyMark Busch,Decker, our Chief Executive Officer and ChairmanPresident of the BoardCompany; Robert Kiernan, our Chief Financial Officer; Alfonzo Leon, our Chief Investment Officer; Danica Holley, our Chief Operating Officer; and Jamie Barber, our Secretary and General Counsel, to manage our operations. Additionally, we rely on several other key personnel to manage our day-to-day operations, including accounting and finance staff, acquisition and due diligence personnel, asset managers and facilities personnel. We cannot guarantee that all, or any one of these key personnel, will remain affiliated with us, especially given the current tightness of the U.S. labor market, nor do we maintain key person life insurance on any person. Our failure to retain key employees and retain highly skilled managerial and operational personnel, could have a material adverse effect on our business, financial condition, results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock.
On January 8, 2025, the Company announced that it had entered into a Transition and Separation Agreement and General Release of Claims with its Chief Executive Officer (“CEO”), Mr. Busch, whereby Mr. Busch will remain CEO until the first to occur of (i) the date that a successor to the position of CEO who has been appointed in accordance with the Board of Directors’ approved succession process begins employment, or (ii) June 30, 2025.
If we fail to qualify as a REIT in any taxable year, we will face serious tax consequences that will substantially reduce the funds available for distributions to our stockholders because we would not be allowed a deduction for dividends paid to stockholders in computing our taxable income and would be subject to U.S. federal income tax at regular corporate rates;:
If a TRS lessee failed to qualify as a TRS or the facility operators engaged by a TRS lessee did not qualify as “eligible independent contractors,” we wouldcould fail to qualify as a REIT and would be subject to higher taxes and have less cash available for distribution to our stockholders.
Additionally, if the facility operators engaged by a TRS lessee do not qualify as “eligible independent contractors,” we wouldcould fail to qualify as a REIT. Each of the facility operators that would enter into a management contract with any TRS lessee must qualify as an “eligible independent contractor” under the REIT rules in order for the rent paid to us by such a TRS lessee to be qualifying income for purposes of the REIT gross income tests. Among other requirements, to qualify as an “eligible independent contractor,” a facility operator must not own, directly or indirectly, more than 35% of our outstanding shares and no person or group of persons can own more than 35% of our outstanding shares and the ownership interests of the facility operator, taking into account certain ownership attribution rules. The ownership attribution rules that apply for purposes of these 35% thresholds are complex. Although we would monitor ownership of our shares of common stock by any facility operators and their owners, there can be no assurance that these ownership levels will not be exceeded.
The maximum U.S. federal income tax rate applicable to “qualified dividend income” payable to U.S. stockholders that are taxed at individual rates is 20% (plus the 3.8% surtax on net investment income, if applicable). Dividends payable by REITs, however, generally are not eligible for the reduced rates on qualified dividend income. Rather, ordinary REIT dividends constitute “qualified business income” and thus a 20% deduction is available to individual taxpayers with respect to such dividends, resulting in a 29.6% maximum U.S. federal income tax rate (plus the 3.8% surtax on net investment income, if applicable) for individual U.S. stockholders. To qualify for this deduction, the stockholder receiving such dividends must hold the dividend-paying REIT stock for at least 46 days (taking into account certain special holding period rules) of the 91-day period beginning 45 days before the stock became ex-dividend and cannot be under an obligation to make related payments with respect to a position in substantially similar or related property. Without further legislative action, the 20% deduction applicable to ordinary REIT dividends will expire on January 1, 2026. The more favorable rates applicable to regular corporate qualified dividends could cause investors who are taxed at individual rates to perceive investments in REITs to be relatively less attractive than investments in the stock of non-REIT corporations that pay dividends, which could adversely affect the value of the shares of REITs, including our common and preferred stock.
We are subject to risks related to corporate social responsibility.
Our business faces public scrutiny related to ESG activities. We risk damage to our reputation if we fail to act responsibly in a number of areas, such as diversity and inclusion, environmental stewardship, support for local communities, corporate governance and transparency and considering ESG factors in our investment processes. There is also some indication that ESG and sustainability goals are becoming more controversial, as some governmental entities and certain investor constituencies question the appropriateness or object to ESG and sustainability initiatives. Adverse incidents with respect to ESG activities could impact the cost of our operations and relationships with investors and tenants, all of which could materially adversely affect our business, financial condition, results of operations, our ability to make distributions to our stockholders and the trading price of our common and preferred stock. Additionally, new legislative or regulatory initiatives related to ESG could adversely affect our business.
The integration of AI tools in the healthcare industry may present significant opportunities and risks, including for our tenants. The adoption of AI tools also introduces a complex risk landscape for our tenants, similar to those risks described above. In addition, the adoption of AI tools by our tenants may also lead to a reconfiguration in space requirements by our tenants or decreased in demand for space over time. If we are not able to offset any material reduction in demand through leasing or re-leasing efforts, repurposing space, property dispositions, or other means, there could be a material adverse effect on our business, results of operations, and financial condition.
Management's Discussion & Analysis (MD&A)
New heading “Note: On September 19, 2025, the Company completed a one-for-five reverse stock split of its outstanding shares of common stock, with a corresponding adjustment to the outstanding partnership units of the Operating Partnership (the “Reverse Stock Split”). Unless otherwise noted, all common share and unit amounts shown below are shown on a split-adjusted basis.”
New heading “Preferred Stock Offering”
New heading “Inaugural Active Adult Investment”
New heading “Net (Loss) Income”
New heading “Funds from Operations, Core Funds from Operations (formerly Adjusted Funds from Operations), and Funds Available for Distribution”
New heading “NOI and Cash NOI”
New heading “Credit Facility”
New heading “Share Repurchase Program”
Removed heading “2024 Executive Summary”
Removed heading “Completed Acquisitions”
Removed heading “Properties Under Contract to Acquire and Acquisitions Completed Subsequent to December 31, 2024”
Removed heading “Completed Property Dispositions”
Removed heading “Impairment of Investment Property”
Removed heading “Capital Raising Activity”
Removed heading “CEO Succession Plan”
Removed heading “Loss on Extinguishment of Debt”
Removed heading “External Sources of Liquidity”
Removed heading “Equity Issuances”
Removed heading “Debt Financing.”
Removed heading “Funds from Operations and Adjusted Funds from Operations”
Largest changes
“The Company calculates EBITDAre in accordance with standards established by NAREIT and defines EBITDAre as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, property impairment losses, and adjustments for unconsolidated partnerships and joint ventures to reflect EBITDAre on the same basis, as applicable. …”see in full comparison
“The Company calculates EBITDAre in accordance with standards established by NAREIT and defines EBITDAre as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, property impairment losses, and adjustments for unconsolidated partnerships and joint ventures, as applicable. …”see in full comparison
“The Company considers net operating income (“NOI”) to be an appropriate supplemental measure to net income because it helps both investors and management understand the core operations of our properties. We define NOI as total net (loss) income, plus depreciation and amortization expenses, general and administrative expenses, transaction expenses, impairments, gain/loss on sale of real estate, interest expense, and other non-operating items. Cash NOI is a key performance indicator. …”see in full comparison
“On January 20, 2026, White Rock Medical Center LLC, filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code. At the time of its bankruptcy filing, White Rock operated two hospitals in Texas, including the White Rock Medical Center in Dallas, Texas, an acute-care hospital owned by the Company where White Rock is the sole tenant and has been operating the hospital since October 2023. There are 12 years remaining on this lease. …”see in full comparison
Full comparison: every changed paragraph (118)
Note: On September 19, 2025, the Company completed a one-for-five reverse stock split of its outstanding shares of common stock, with a corresponding adjustment to the outstanding partnership units of the Operating Partnership (the “Reverse Stock Split”). Unless otherwise noted, all common share and unit amounts shown below are shown on a split-adjusted basis.
GlobalChiron MedicalReal REITEstate Inc. (the “Company,” “us,” “we,” or “our”) is a Maryland corporation and internally managed REIT that primarily acquires healthcare facilities and leases those facilitiesleased to physician groups and regional and national healthcare systems. We hold our facilities and conduct our operations through a Delaware limited partnership subsidiary, GlobalChiron MedicalReal REITEstate L.P.LP (the “Operating Partnership”). Our wholly owned subsidiary, GlobalChiron MedicalReal REITEstate GP LLC, is the sole general partner of our Operating PartnershipPartnership. and, asAs of December 31, 2024,2025, we owned 92.6%92.0% of the outstanding common operating partnership units (“OP Units”) of our Operating Partnership,, with an aggregate of 7.4% of the Operatingremaining Partnership8.0% owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. On February 23, 2026, the Company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc.
Our revenues are derived from the rental and operating expense reimbursement payments we receive from our tenants, and most of our leases are medium to long-term triple net leases with contractual rent escalation provisions. Our primary expenses are depreciation, interest, and general and administrative expenses. We finance our acquisitions with a mixture of debt and equity primarily from our cash from operations, borrowings under our SecondThird Amended and Restated Credit Facility (the “Credit Facility”), and stock issuances.
2024 Executive Summary
The following tables summarize the primary changes in our business and operations during the years presented.
As of December 31, 2024,2025, ourwe portfoliohad consistedgross investments of grossapproximately investment$1.5 billion in real estateestate, consisting of $1.5189 billion,buildings with an aggregate of 4.8approximately 5.1 million leasable square feet and anapproximately aggregate $110$118.8 million of annualized base rent. This data does not include amounts for properties held in our unconsolidated joint venture.
Completed Acquisitions
During the year ended December 31, 2024 we completed the acquisition of a 15-property portfolio of outpatient medical real estate. In aggregate the portfolio had a purchase price of $80.3 million with 254,220 leasable square feet and annualized base rent of $6.4 million.
Properties Under Contract to Acquire and Acquisitions Completed Subsequent to December 31, 2024
In October 2024, we entered into a purchase agreement to acquire a five-property portfolio (the “five-property portfolio”) of medical real estate for an aggregate purchase price of $69.6 million. In February 2025, we completed the acquisition of three properties in the five-property portfolio encompassing an aggregate of 188,874 leasable square feet for an aggregate purchase price of $31.5 million with aggregate annualized base rent of $2.8 million. We expect to complete the acquisition of the remaining two properties in the five-property portfolio, with an aggregate purchase price of $38.1 million, during the second quarter of 2025. The Company’s obligation to close the acquisition of the remaining two properties in the five-property portfolio is subject to certain customary terms and conditions, including due diligence reviews. Accordingly, there is no assurance that we will close this acquisition on the terms described above, or at all.
Completed Property Dispositions
During the year ended December 31, 2024, we completed seven dispositions that generated aggregate gross proceeds of $60.7 million, resulting in an aggregate gain of $4.2 million. Of the $60.7 million of gross disposition proceeds in 2024, $35.2 million were related to the sale of two properties to a joint venture between us and Heitman (the “Joint Venture”), whereby Heitman maintains an 87.5% equity investment and we maintain a 12.5% equity investment in the Joint Venture.
Impairment of Investment Property
During the year ended December 31, 2024, we recognized an impairment loss of $1.7 million related to our Derby, Kansas facility.
Capital Raising Activity
In January 2024, the Company and the Operating Partnership implemented a $300 million “at-the-market” equity offering program, pursuant to which we may offer and sell (including through forward sales), from time to time, shares of our common stock (the “2024 ATM Program”).
During the year ended December 31, 2024, we generated gross proceeds of $12.0 million through ATM equity issuances of 1.2 million shares of our common stock at an average offering price of $9.95 per share.
Debt2025 Investment Activity
During 2025, the Company completed the acquisition of a five-property portfolio of medical real estate. In aggregate the portfolio had a purchase price of $69.6 million with 486,598 leasable square feet and annualized base rent of $6.3 million.
During 2025, the Company completed seven dispositions that generated aggregate net proceeds of $23.0 million, resulting in an aggregate net gain of $1.5 million. In addition, we recognized impairment losses on the sold assets of $13.0 million.
Preferred Stock Offering
On November 20, 2025, the Company sold 2,050,000 shares of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share, with a liquidation preference of $25 per share, inclusive of 50,000 shares issued in connection with the underwriters’ exercise of their over-allotment option. The Company may, at its option, redeem the Series B Preferred Stock for cash in whole or in part, from time to time, at any time on or after November 20, 2030, at a cash redemption price of $25 per share, plus accrued and unpaid dividends. The Series B Preferred Stock generally has no voting rights, except for limited voting rights if the Company fails to pay dividends for six quarterly periods and on certain fundamental matters that may affect the preference or special rights of the Series B Preferred Stock. The issuance resulted in aggregate gross proceeds of $51.3 million. After deducting underwriting discounts and advisory fees of $1.6 million, and expenses paid by the Company that were directly attributable to the offering of $0.5 million (which are both treated as a reduction of the “Preferred Stock” balance on the accompanying Consolidated Balance Sheets), the Company’s Series B Preferred Stock balance as of December 31, 2025 was $49.1 million. The net proceeds received from the transaction were primarily used to repay borrowings on the revolver component of the Credit Facility.
During the year ended December 31, 2024, we borrowed $143.8 million under our Credit Facility and repaid $99.6 million, for a net amount borrowed of $44.2 million. As of December 31, 2024, the net outstanding Credit Facility balance was $631.7 million and as of February 26, 2025, we had unutilized borrowing capacity under the Credit Facility of $219.4 million.
Joint Venture
In December 2024, we entered into the Joint Venture with Heitman, a real estate investment firm with over $48 billion of assets under management. Pursuant to the Joint Venture operating agreement, we maintain a 12.5% investment in the Joint Venture and also serve as its managing member and Heitman maintains an 87.5% investment. Most economic decisions related to the Joint Venture are determined by the majority vote of an executive committee that consists of three members representing Heitman and two members representing our Company. As the managing member, we source new investments for the Joint Venture, manage the day-to-day activities of the Joint Venture and its assets, earn fees as compensation for such services, and are entitled to reimbursement of certain expenses we incur in the performance of such services. Pursuant to the terms of the Joint Venture operating agreement, we have the right to purchase investment opportunities for the Company before offering such opportunities to the Joint Venture.
In connection with the formation of the Joint Venture, we sold two of our assets to the Joint Venture (the “Seed Portfolio”) receiving gross proceeds of $35.2 million. We used $2.1 million of the sale proceeds from the Seed Portfolio to finance our initial 12.5% capital investment in the Joint Venture. In connection with the acquisition of the Seed Portfolio, the Joint Venture entered into a mortgage loan with a principal amount of $17.6 million.
Inaugural Active Adult Investment
On January 6, 2026, the Company entered into a joint venture with a developer to facilitate the development of a 132-unit, active adult residential community in a suburb of Minneapolis, Minnesota (the “Active Adult Joint Venture”). We invested $7.1 million for a 49% equity interest in the Active Adult Joint Venture, with the developer retaining a 51% interest. The Active Adult Joint Venture entered into a construction loan with a principal balance of $31.0 million. The developer is serving as the managing member of the Active Adult Joint Venture.
CEO Succession Plan
On January 8, 2025, the Company and Jeffrey Busch, Chairman of the Board and Chief Executive Officer, reached an agreement regarding Mr. Busch’s transition from service as the Company’s Chief Executive Officer and anticipated continuation as a member of the Company’s Board. Pursuant to a Transition and Separation Agreement and General Release of Claims dated as of January 8, 2025 (the “Separation Agreement”), Mr. Busch, the Company and Inter-American Management LLC (“Inter-American”) agreed that Mr. Busch’s employment, and service as Chief Executive Officer and President of the Company and Inter-American, would end no later than the first to occur of (i) the date that a successor to the position of Chief Executive Officer who has been appointed in accordance with the Board’s approved succession process begins employment, or (ii) June 30, 2025 (such date that is the first to occur, the “Succession Date”). The Board has directed the Nominating and Corporate Governance Committee of the Board to conduct a comprehensive search process to identify a new Chief Executive Officer with the assistance of an executive search firm. Mr. Busch intends to stand for re-election as a director at the Company’s 2025 annual meeting of stockholders, and it is expected that he will continue to serve as non-executive Chairman of the Board following the Succession Date. Mr. Busch’s departure is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.
Pursuant to the Separation Agreement, and in consideration for Mr. Busch (i) assisting with the transition to the new Chief Executive Officer and continuing in employment through the Succession Date, (ii) executing, and not revoking, releases of claims in favor of the Company, and (iii) otherwise satisfying the terms of the Separation Agreement, Mr. Busch will receive separation benefits to which he is entitled under that certain Employment Agreement between Mr. Busch and the Company effective as of July 9, 2020 and later amended by that certain letter agreement dated January 27, 2021 following his cessation of employment.
For the year ended December 31, 2024 the Company accrued $3.2 million for cash severance related costs included in the “Accounts Payable and Accrued Expenses” line item on the Company’s Consolidated Balance Sheets with the expense included in the “General and Administrative Expense” line item on the Company’s Consolidated Statements of Operations.
Chapter 11 BankruptcyReorganization Filing of ProspectWhite Rock Medical GroupCenter, LLC
On January 20, 2026, White Rock Medical Center LLC, filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code. At the time of its bankruptcy filing, White Rock operated two hospitals in Texas, including the White Rock Medical Center in Dallas, Texas, an acute-care hospital owned by the Company where White Rock is the sole tenant and has been operating the hospital since October 2023. There are 12 years remaining on this lease. According to the filed bankruptcy documents, the primary reason for the bankruptcy is a dispute with the former operator of the facility related to amounts due to the former operator. Accordingly White Rock plans to (i) restructure indebtedness related to its purchase of the hospital operations at the White Rock Medical Center and a related transition services agreement and (ii) sell its hospital operations to a third party, with the goal of stabilizing its operations and maximizing value to its stakeholders. As a means of assisting White Rock in its stabilization efforts, the Company has funded annual property tax obligations due under the lease and accepted reduced monthly payments. As of February 20, 2026, the Company has a receivable balance, net of security deposits, of approximately $1.4 million (exclusive of late fees and interest thereon). Although we expect White Rock to affirm our lease as part of its reorganization plan, as of February 20, 2026, no reorganization plan has been filed with the courts and there can be no assurance that White Rock will affirm its lease with us or that we will receive any amounts owed to us.
On January 11, 2025, our tenant, Prospect Medical Group (“Prospect”), filed for Chapter 11 bankruptcy reorganization. As of January 11, 2025, Prospect owed us approximately $2.4 million related to leases at three of our healthcare facilities, including $2.2 million related to our facility in East Orange, New Jersey. As of February 26, 2025, Prospect had not yet decided if it was going to accept or reject its leases with us. If Prospect rejects any of its leases with us, we would have a general unsecured claim with respect to amounts owed under any rejected lease.
Continued elevated interest rates have contributed to a continued lull in the common stock prices of many REITs, including the price of the Company’s common stock. A continued low stock price and elevated interest rates have caused the Company’s cost of capital to remain elevated, which, in turn, has significantly reduced the ability to acquire assets that meet the Company’s investment requirements.
All of our facility acquisitions for the years ended December 31, 20242025 and 20232024 were accounted for as asset acquisitions because substantially all of the fair value of the gross assets that we acquired were concentrated in a single asset or group of similar identifiable assets. Accordingly, the purchase prices of acquired tangible and intangible assets and liabilities were recorded and allocated at fair value on a relative basis. The recorded allocations are based on estimated cash flow projections of the properties acquired, which incorporates discount, capitalization and interest rates as well as available comparable market information. We use considerable judgement in our estimates of cash flow projections, discount, capitalization and interest rates, fair market lease rates, carrying costs during hypothetical expected lease-up periods, and costs to execute similar leases.
While our methodology for purchase price allocations did not change during the year ended December 31, 2024,2025, the real estate market is fluidfluid, and our assumptions are based on information currently available in the market at the time of acquisition. Significant increases or decreases in these key estimates, particularly with regards to cash flow projections and discount and capitalization rates, would result in a significantly lower or higher fair value allocated to acquired tangible and intangible assets and liabilities.
Total revenue for the year ended December 31, 20242025 was $138.8$148.2 million, compared to $141.0$138.8 million for the same period in 2023,2024, aan decreaseincrease of $2.2$9.4 million. The decreaseincrease primarily resulted from the full yearnet impact of threeacquisitions propertyand dispositions that were completed during the year ended December 31, 20232024 and the impact from seven property dispositions that were completed during the year ended December 31, 2024, partially offset by the impact of 15 properties that were acquired in 2024.2025. Within that decrease,increase, $19.4$2.4 million represents an increase in revenue was recognized from net lease expense recoveries duringin the year ended December 31, 2024,2025 compared to $19.5 million for the same period in 2023.2024.
General and administrative expenses for the year ended December 31, 20242025 were $21.1$20.0 million, compared to $16.9$21.1 million for the same period in 2023,2024, ana increasedecrease of $4.2$1.1 million. The increasedecrease primarily resulted from $3.2 million that was expensed in 2024 related to cash severance costs owed to Mr. Jeffery Busch, our Chairman andformer Chief Executive Officer, pursuant to the Transition and Separationa Agreement and General Release of Claims, dated January 8, 2025, by and among the Company, Inter-American Management LLC and Mr. Busch, and an increasedecrease in non-cash LTIP compensation expense, which was $5.1$4.5 million for the year ended December 31, 2024,2025, compared to $4.2$5.1 million for the same period in 2023.2024.
Operating expenses for the year ended December 31, 20242025, were $29.3$32.6 million, compared with $28.1$29.3 million for the same period in 2023,2024, an increase of $1.2$3.3 million. WhileThe increase primarily resulted from the increase compared to 2023 was not significant, the increase relative to revenue reflects thenet impact of tenants placed on cash basis accounting in the fourth quarter of 2023acquisitions and thedispositions secondduring quarter2024 ofand 2024, partially offset by a net reduction in costs at other properties.2025. Included in these amounts were $19.4$21.8 million of recoverable property operating expenses incurred during the year ended December 31, 2024,2025, compared to $19.5$19.4 million for the same period in 2023.2024. In addition, our operating expenses included $5.7$6.3 million of non-recoverable property operating expenses from gross leases for the year ended December 31, 2024,2025, compared to $5.9$5.7 million for the same period in 2023.2024.
Depreciation expense for the year ended December 31, 20242025 was $40.4$44.0 million, compared to $41.3$40.4 million for the same period in 2023,2024, aan decreaseincrease of $0.9$3.6 million. The decreaseincrease primarily resulted from the full yearnet impact of threeacquisitions propertyand dispositions that were completed during the year ended December 31, 20232024 and the2025. impactThis from seven property dispositions that were completed during the year ended December 31, 2024,was partially offset by thea impact of 15 properties that were acquireddecrease in 2024.our existing portfolio due to fully depreciated tenant improvements.
Amortization expense for the year ended December 31, 20242025 was $14.9$15.0 million, compared to $16.9$14.9 million for the same period in 2023,2024, aan decreaseincrease of $2.0$0.1 million. The decreaseincrease primarily resulted from the full yearnet impact of threeacquisitions propertyand dispositions that were completed during the year ended December 31, 20232024 and the2025. impactThis from seven property dispositions that were completed during the year ended December 31, 2024,was partially offset by thea impact of 15 properties that were acquireddecrease in 2024.our existing portfolio due to fully amortized lease intangibles.
Interest expense for the year ended December 31, 20242025 was $28.7$31.8 million, compared to $30.9$28.7 million for the same period in 2023,2024, aan decreaseincrease of $2.2$3.1 million. This decreaseincrease was due to lowerhigher interest rates and lower averagenet borrowings on the credit facility during the year ended December 31, 2024,2025, compared to the same period in 2023.2024.
The weighted average interest rate of our debt for the year ended December 31, 20242025 was 3.94%3.98% compared to 4.12%3.94% in 2023.2024. Additionally, the weighted average interest rate and term of our debt was 3.74% and 4.1 years, respectively, at December 31, 2025, compared to 3.75% and 2.0 years, respectively, at December 31, 2024.
Income before other income (expense) for the year ended December 31, 20242025 was $4.2$4.8 million, compared to $7.0$4.2 million for the same period in 2023,2024, aan decreaseincrease of $2.8$0.6 million.
During the year ended December 31, 2025, we completed seven dispositions resulting in an aggregate gain of $1.5 million. During the year ended December 31, 2024, we completed seven dispositions resulting in an aggregate gain of $4.2 million.
During the year ended December 31, 2024, we completed seven dispositions resulting in an aggregate gain of $4.2 million. During the year ended December 31, 2023, we completed three dispositions resulting in an aggregate gain of $15.6 million.
Impairment of Investment PropertyProperties
During the years ended December 31, 2025 and 2024, we had the following impairments in investment properties:
In December 2024, we entered into an agreement to sell our facility located in Derby, Kansas. We recognized an impairment loss of $1.7 million during the fourth quarter of 2024 to reduce the carrying value of the asset to its fair value, which was determined to be the contractual sales price less commissions and fees. The sale of this facility was completed in February 2025.
During the year ended December 31, 2024, we recognized a loss from the unconsolidated Joint Venture of $20 thousand, which represented our 12.5% ownership interest in the net loss of the Joint Venture from December 20, 2024, when the Joint Venture was formed, through December 31, 2024.
Loss on Extinguishment of Debt
In December 2023, we completed the defeasance of a CMBS loan resulting in a loss on extinguishment of debt of $0.9 million.
Net Income
NetEquity incomeloss from the unconsolidated Joint Venture for the year ended December 31, 20242025 was $6.7$150 millionthousand compared to $21.7$20 millionthousand for the same period in 2023,2024, aan decreaseincrease of $15.0$130 million.thousand.
Net (Loss) Income
Net loss for the year ended December 31, 2025 was $6.9 million compared to net income of $6.7 million for the same period in 2024, a decrease of $13.6 million.
As of December 31, 20242025 and 2023,2024, our principal assets consisted of investments in real estate, net, of $1.2 billion. We completed thefive acquisition of a 15-property portfolioacquisitions and completed seven disposition transactionsdispositions during the year ended December 31, 2024.2025. Our liquid assets consisted primarily of cash and cash equivalents and restricted cash of $8.9$11.9 million and $6.7$8.9 million, as of December 31, 20242025 and 2023,2024, respectively.
The increase in our cash and cash equivalents and restricted cash balances of $11.9 million as of December 31, 2025, compared to $8.9 million as of December 31, 2024, compared to $6.7 million as of December 31, 2023, was primarily due to net cashborrowings providedon byour operatingCredit activities,Facility, net proceeds received from the sale of shares of our Series B preferred stock, net proceeds received from the sale of investment properties, net borrowings on our Credit Facility, and net proceedscash receivedprovided fromby ATMoperating equity issuances,activities, partially offset by funds used to acquire investment properties, the payment of dividends to our common and preferred stockholders andas well as holders of OP Units and LTIP Units, funds used to repurchase common stock, funds used to repay notes payable, and funds used for capital expenditures on existing real estate investments and leasing commissions, the repayment of notes payable, and funds we invested in an unconsolidated joint venture.commissions.
What changed in the latest 10-Q
Risk Factors
Largest changes
see in full comparisonIf we acquire the Riviera and the Landing, we plan to establish a new SHOP segment. ThisOur SHOP segment may expose us to various operational risks, liabilities and claims that could adversely affect our ability to generate revenues or increase our costs and could adversely affect our business, financial condition and results of operations.
Under the REIT tax rules, the senior housing communities in oursee in full comparisonpotentialSHOP segment that are “qualified healthcare properties” generally must be operated and managed for us by third-party managers and we have limited rights to direct or influence the business or operations of those communities.We expect that bothBoth our qualified and non-qualified healthcare properties in our SHOP segmentwill beare managed or sub-managed by third-party managers. However, in each case, wewillnonetheless participate directly in the financial performance of the communities’ operations andwill beare ultimately responsible for all operational risks and other liabilities of such properties, other than those arising out of certain actions by our managers, such as gross negligence, fraud or willful misconduct. These risks include, and our financial performancewill beis impacted by, among other things, fluctuations in occupancy levels, the inability to charge desirable resident fees (including anticipated increases in those fees), increases in the cost of food, supplies, energy, labor (as a result of labor shortages, unionization, inflation or otherwise) or other services, rent control regulations, national and regional economic conditions, the imposition of new or increased taxes, capital expenditure requirements, changes in management or equity, accounting misstatements, professional and general liability claims, litigation and regulatory actions and the availability and cost of insurance. Additionally, new or smaller third-party managers may have less experience in managing these senior housing communities and may require more oversight or attention. Any one or a combination of these factors could impact the performance of ourpotentialSHOP segment, which could adversely affect our business, financial condition and results of operations.
see in full comparisonIf we establish a SHOP segment, we mayWe lease certain of our seniors housing facilities to our TRS lessee, whichwould contractcontracts with managers to manage the healthcare operations at those facilities. Our ability to use this TRS lessee structure may be limited by the ability of those seniors housing facilities to qualify as “qualified healthcare properties” and the ability of the managers who our TRS lessee engages to manage the “qualified healthcare properties” to qualify as “eligible independent contractors.”
Full comparison: every changed paragraph (15)
If we acquire the Riviera and the Landing, we plan to establish a new SHOP segment. ThisOur SHOP segment may expose us to various operational risks, liabilities and claims that could adversely affect our ability to generate revenues or increase our costs and could adversely affect our business, financial condition and results of operations.
Under the REIT tax rules, the senior housing communities in our potential SHOP segment that are “qualified healthcare properties” generally must be operated and managed for us by third-party managers and we have limited rights to direct or influence the business or operations of those communities. We expect that bothBoth our qualified and non-qualified healthcare properties in our SHOP segment will beare managed or sub-managed by third-party managers. However, in each case, we will nonetheless participate directly in the financial performance of the communities’ operations and will beare ultimately responsible for all operational risks and other liabilities of such properties, other than those arising out of certain actions by our managers, such as gross negligence, fraud or willful misconduct. These risks include, and our financial performance will beis impacted by, among other things, fluctuations in occupancy levels, the inability to charge desirable resident fees (including anticipated increases in those fees), increases in the cost of food, supplies, energy, labor (as a result of labor shortages, unionization, inflation or otherwise) or other services, rent control regulations, national and regional economic conditions, the imposition of new or increased taxes, capital expenditure requirements, changes in management or equity, accounting misstatements, professional and general liability claims, litigation and regulatory actions and the availability and cost of insurance. Additionally, new or smaller third-party managers may have less experience in managing these senior housing communities and may require more oversight or attention. Any one or a combination of these factors could impact the performance of our potential SHOP segment, which could adversely affect our business, financial condition and results of operations.
Our inability to renew our management agreements with our potential SHOP managers and sub-managers on as favorable terms or at all, and our inability when necessary, to effectively and efficiently transition a SHOP community to a new manager or sub-manager, may have an adverse effect on our business, financial condition and results of operations.
IfWe we establish a SHOP segment, we will beare party to management agreements with our SHOP managers and sub-managers. While our management and sub-management agreements may be renewed, either pursuant to pre-negotiated renewal rights or through negotiation, there can be no assurance that our managers or sub-managers will renew with us. Even if a manager or sub-manager renews its agreement with us, we cannot assure you that the renewals will be on favorable terms. This risk may be exacerbated if market conditions at the time of the renewal are not as favorable as they were at the time the agreement was initially entered into or if the manager or sub-manager is subject to financial or operational difficulties.
Our management and sub-management agreements will provide us and our managers and sub-managers with termination rights in certain circumstances. If our management or sub-management agreements are not renewed or are otherwise terminated, we may attempt to transition those properties to one or more managers or sub-managers or reposition those properties for an alternative use. We may not be successful in identifying suitable replacements or entering into management or sub-management agreements or other arrangements with new managers or sub-managers on a timely basis or on terms as favorable to us as our current management or sub-management agreements, if at all.
If we establish a SHOP segment, significantSignificant legal or regulatory proceedings could subject us or our managers or sub-managers to increased operating costs and substantial uninsured liabilities, which could adversely affect our or their liquidity, financial condition and results of operations.
If we establish a SHOP segment, fromFrom time to time, we or our managers or sub-managers may be subject to lawsuits, investigations, claims and other legal or regulatory proceedings arising out of our or their alleged actions or inactions. Also, in certain circumstances, regardless of whether we are a named party in a lawsuit, investigation, claim or other legal or regulatory proceeding, we may be contractually obligated to indemnify, defend and hold harmless our managers, sub-managers and other third parties against, or may otherwise be responsible for such actions, proceedings or claims. These claims may include, among other things, professional liability and general liability claims, commercial liability claims, unfair business practices claims, class action claims, employment-related claims, as well as regulatory proceedings, including proceedings related to our SHOP segment, where we are typically the holder of the applicable healthcare license. In addition, some of our properties may be in states in which the litigation environment may pose a significant business risk to us.
In our potential operating assets, we will be generally responsible for all liabilities of the properties, including any lawsuits, investigations, claims and other legal or regulatory proceedings, other than those arising out of certain limited actions by our managers or sub-managers, such as those caused by gross negligence, fraud or willful misconduct. As a result, we will have exposure to, among other things, professional and general liability claims, employment-related claims and the associated litigation and other costs related to defending and resolving such claims, some of which may be uninsured, either as a result of insufficient coverage or unavailability of coverage at a reasonable price.
If we establish a SHOP segment, eventsEvents that adversely affect the ability of seniors and their families to afford resident fees at our seniors housing facilities could cause our occupancy rates, revenues and results of operations to decline.
If we establish a SHOP segment, ourOur ability to lease certain of our potential seniors housing facilities to our TRS lessee will be limited by the ability of those seniors housing facilities to qualify as “qualified healthcare properties.”
If we establish a SHOP segment, we mayWe lease certain of our seniors housing facilities to our TRS lessee, which would contractcontracts with managers to manage the healthcare operations at those facilities. Our ability to use this TRS lessee structure may be limited by the ability of those seniors housing facilities to qualify as “qualified healthcare properties” and the ability of the managers who our TRS lessee engages to manage the “qualified healthcare properties” to qualify as “eligible independent contractors.”
If we establish a SHOP segment and our TRS lessee failed to qualify as a TRS or the facility managers engaged by our TRS lessee do not qualify as “eligible independent contractors,” we could fail to qualify as a REIT and could be subject to higher taxes.
Rent paid by a lessee that is a “related party tenant” of ours will not be qualifying income for purposes of the two gross income tests applicable to REITs. If we establish a SHOP segment, we mayWe lease certain of our potential seniors housing facilities that qualify as “qualified healthcare properties” to our TRS lessee. So long as our TRS lessee qualifies as a TRS, it will not be treated as a “related party tenant” with respect to our “qualified healthcare properties” that are managed by an independent facility manager that qualifies as an “eligible independent contractor.” We expect that our TRS lessee will qualify to be treated as a TRS for U.S. federal income tax purposes, but there can be no assurance that the IRS will not challenge the status of our TRS lessee for U.S. federal income tax purposes or that a court would not sustain such a challenge. If the IRS were successful in disqualifying our TRS lessee from treatment as a TRS, we could fail to meet the asset tests applicable to REITs and we could fail to satisfy the gross income tests. If we failed to meet either the asset or gross income tests, we could lose our REIT qualification for U.S. federal income tax purposes unless we qualified for application of statutory savings provisions.
If we establish a SHOP segment, theThe ability of our TRSs to manage certain of our potential independent living facilities will be dependent on such facilities not constituting “qualified healthcare properties.”
If we establish a SHOP segment, we plan toWe engage TRSs to manage certain of our independent living facilities. Our ability to utilize TRSs in such a role depends on those independent living facilities not constituting “qualified healthcare properties” within the meaning of the U.S. federal income tax rules applicable to REITs. While we believe that such independent living facilities are not “qualified healthcare properties,” if the IRS challenged such belief and a court sustained such a challenge, our income from the properties could fail to qualify as rents from real property for purposes of the REIT gross income tests, and as a result we could fail to qualify as a REIT.
Management's Discussion & Analysis (MD&A)
New heading “Acquired Properties”
New heading “Properties Under Contract”
New heading “Real Estate Loans”
New heading “2026 Disposition Activity”
New heading “Segment Results”
New heading “Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025”
New heading “General and Administrative”
New heading “Operating Expenses”
New heading “Depreciation Expense”
New heading “Amortization Expense”
New heading “Interest Expense”
New heading “Income Before Other Income (Expense)”
New heading “Gain on Sale of Investment Properties”
New heading “Equity Loss from Unconsolidated Joint Ventures”
New heading “Series C Convertible Preferred Stock Offering”
New heading “Off-Balance Sheet Arrangements”
Removed heading “Contracts to Purchase Seniors Housing Communities”
Removed heading “The Landing Alexandria”
Removed heading “The Riviera at Alexandria”
Removed heading “The Pinnacle North Bethesda”
Removed heading “$100 Million Strategic Convertible Perpetual Preferred Equity Investment”
Removed heading “Common Dividend Modification”
Removed heading “Chapter 11 Reorganization Filing of White Rock Medical Center, LLC”
Largest changes
“On May 29, 2026 and June 2, 2026, the Company issued and aggregate of 1,000,000 shares of its Series C Convertible Preferred Stock, for aggregate gross proceeds of $100.0 million. …”see in full comparison
“Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025”see in full comparison
“$100 Million Strategic Convertible Perpetual Preferred Equity Investment”see in full comparison
“Chapter 11 Reorganization Filing of White Rock Medical Center, LLC”see in full comparison
Full comparison: every changed paragraph (109)
This Report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). In particular, statements pertaining to our investment in our Series C Preferred Stock or the terms of the investment agreement by Maewyn Capital Partners and its affiliates, future Board composition, trends, liquidity, capital resources, future dividends, andpending acquisitions, potential sales, the healthcare industry andindustry, the healthcare real estate markets and opportunity,seniors housing opportunities, among others, contain forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology including, but not limited to, “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates” or “anticipates” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions.
Chiron Real Estate Inc. (the “Company”) is a Maryland corporation and internally managed real estate investment trust (“REIT”) that owns (i) healthcare facilities leased to physician groups and regional and national healthcare systems and (ii) seniors housing communities. The Company’s seniors housing includes independent living communities (“IL”), assisted living communities (“AL”), memory care communities (“MC”) and active adult communities. As of June 30, 2026, the Company’s total gross investment portfolio consisted of 82% healthcare facilities, primarily outpatient medical facilities, 16% seniors housing operating portfolio (“SHOP”) assets, and 2% unconsolidated joint ventures and other investments.
ChironThe RealCompany Estateholds Inc. (the “Company,” “us,” “we,” or “our”) is a Maryland corporation and internally managed REIT that acquires (i) healthcare facilities leased to physician groups and regional and national healthcare systems and (ii) seniors housing communities. We hold ourits facilities and conductconducts ourits operations through a Delaware limited partnership subsidiary, Chiron Real Estate LP (the “Operating Partnership”). OurThe Company serves as the sole general partner of the Operating Partnership through a wholly owned subsidiary,subsidiary of the Company, Chiron Real Estate GP LLC, isa Delaware limited liability company. As of June 30, 2026, the sole general partner of our Operating Partnership and, as of March 31, 2026, weCompany owned 91.4%91.3% of the outstanding common operating partnership units (“OP Units”), with the remaining 8.6%8.7% owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units.
Our revenues are derived from the rental and operating expense reimbursement payments we receive from our tenants, and most of our leases are medium to long-term triple net leases with contractual rent escalation provisions. We also derive revenue from resident agreements at our SHOP communities. Our primary expenses are depreciation, interest, property operating and general and administrative expenses. We finance our acquisitions with a mixture of debt and equity primarily from our cash from operations, borrowings under our Credit Facility, and stock issuances.
OurWe have expanded our business strategy is to investfocus primarily on investments in healthcareseniors propertieshousing communities that provide an attractive rate of return relative to our cost of capital and are operatedin byattractive profitablemarkets physicianwith groups,favorable regionaldemographic or national healthcare systems or combinations thereof.trends. We believe thisthese strategyasset allowsclasses usare well positioned to attainbenefit from the growing needs of an aging population and support our goals of providing stockholders with (i) attractive dividends and (ii) stock price appreciation. ToWe implementare thisfocused strategy,on wetransitioning seekour asset base from one historically concentrated in outpatient medical facilities to invest:one more heavily weighted toward seniors housing communities.
We also intend to utilize our experience and knowledge of inpatient rehabilitation facilities and outpatient medical real estate to manage our existing joint ventures and to evaluate healthcare real estate opportunities that complement our seniors housing strategy.
Most of our legacy healthcare facilities are leased to single-tenantssingle tenants under triple-net leases. Our portfolio also contains some multi-tenant properties with gross lease or modified gross lease structures. In addition, aswe own SHOP communities from which we derive revenue from resident agreements. As of MarchJune 31,30, 2026, we also had an interest in twofour unconsolidated joint ventures that own or are developing healthcare and active adult facilities.
As of MarchJune 31,30, 2026, we had gross investments of approximately $1.5$1.6 billion in real estate, consisting of 189182 buildingshealthcare facilities, primarily outpatient medical facilities, with an aggregate of approximately 5.14.6 million leasable square feetfeet, and approximately2 $118.2SHOP millioncommunities, with an aggregate of annualized292 base rent.homes. This data does not include amounts for properties held in our unconsolidated joint ventures.
Acquired Properties
On June 1, 2026, the Company completed the acquisition of The Landing Alexandria (the “Landing”), a 163-home, luxury seniors housing community located in Alexandria, Virginia, from affiliates of Silverstone Senior Living (“SSL”) for a purchase price of approximately $130 million. The Landing has operated since May 2022 and offers independent living, assisted living and memory care.
On June 1, 2026, the Company completed the acquisition of The Riviera at Alexandria (the “Riviera”), a 129-home, luxury seniors housing community located in Alexandria, Virginia, from affiliates of SSL for a purchase price of approximately $119 million. The Riviera is a newly developed independent living community that opened in March 2026 and remains in lease-up.
The Company operates the Landing and the Riviera as SHOP communities and one of its taxable REIT subsidiaries (“TRS”) has engaged an affiliate of Greystone Communities to manage the day-to-day operations of the communities. Under this structure, the Company owns the real estate and participates directly in the operating results of the communities, including revenues and operating expenses, rather than receiving fixed lease payments from a third-party tenant.
Properties Under Contract
On May 6, 2026, the Company entered into an agreement to acquire The Pinnacle North Bethesda (the “Pinnacle”), a newly constructed luxury senior housing community located in North Bethesda, Maryland, from an affiliate of SSL for a purchase price of approximately $176 million, subject to customary closing conditions and purchase price adjustments. The Pinnacle is expected to contain 175 homes, including independent living, assisted living, and memory care homes, together with ground floor retail. The closing of the Pinnacle acquisition is expected to occur on or before October 2026, subject to the satisfaction or waiver of customary closing conditions.
On July 10, 2026, the Company entered into a purchase agreement with SSL to acquire a parcel of land located in Reston, Virginia for a purchase price of approximately $15.0 million. The Company expects that a seniors housing community will be developed on the land. The acquisition remains subject to customary closing conditions and is expected to close in August 2026.
On August 3, 2026, the Company entered into an agreement to sell its surgical hospital in Beaumont, Texas for approximately $49 million to an affiliate of a Delaware statutory trust (“DST”). The Company expects to receive proceeds from the sale as beneficial interests in the DST are sold to investors.
There can be no assurance that acquisitions or dispositions will be completed on the anticipated timeline or at all.
Joint Ventures
On January 6, 2026, the Company entered into a joint venture with a developer to facilitate the development of a 132-unit,132-home, active adult residential community in a suburb of Minneapolis, Minnesota (the “Maple Grove Active Adult Joint Venture”). We invested $7.1 million for a 49% equity interest in the Maple Grove Active Adult Joint Venture, with the developer retaining a 51% interest. The Maple Grove Active Adult Joint Venture entered into a construction loan with a principal balance of $31.0 million.million, of which $10.1 million was drawn on as of June 30, 2026. The developer is serving as the managing member of the Maple Grove Active Adult Joint Venture. We account for our interest in the Maple Grove Active Adult Joint Venture using the equity method of accounting.
On May 13, 2026, the Company entered into a joint venture with a developer to facilitate the development of an active adult residential community near Hudson, Wisconsin (the “Hudson Active Adult Joint Venture”). We invested $6.7 million for a 49% equity interest, with the developer retaining a 51% interest and serving as the managing member. We account for our interest in the Hudson Active Adult Joint Venture using the equity method of accounting.
On June 10, 2026, the Heitman OM Joint Venture acquired an additional medical office building located near Minneapolis, Minnesota, for a purchase price of $10.3 million, with the Company contributing its 12.5% proportionate share of the purchase price in accordance with the joint venture agreement. The Heitman OM Joint Venture has obtained two mortgage loans with a total principal balance of $22.9 million.
On June 29, 2026, the Company completed the sale of seven inpatient rehabilitation facilities (“IRFs”) to a newly formed joint venture (the “IRF Joint Venture”) between the Company, through its Operating Partnership, and a U.S. public pension fund (the “IRF JV Partner”). The portfolio was valued at an aggregate purchase price of $217 million and comprised approximately 456,000 square feet of space that was 100% leased with a weighted average remaining lease term of eight years. In connection with the transaction, the Company received net proceeds of $211.4 million, before funding its $16.3 million retained equity investment in the IRF Joint Venture, and recognized a gain on the sale of investment properties of $71.9 million. The IRF JV Partner acquired an 85% equity interest and controls the IRF Joint Venture through its voting interest, while the Company acquired a 15% equity interest, serves as manager of the joint venture, and continues to oversee asset management in exchange for a management fee. The IRF Joint Venture obtained a mortgage loan with a principal balance of $108.5 million, and the Company accounts for its retained interest using the equity method of accounting.
Real Estate Loans
On April 1, 2026, the Company originated a $3.0 million mezzanine loan secured by interests in an entity that owns an under-development medical facility located in Fort Myers, Florida, of which $2.9 million was drawn as of June 30, 2026. The medical facility is an on-campus outpatient surgical facility that is 100% pre-leased to an investment-grade tenant under a 15-year lease. The loan bears interest at a rate of 12.0% per annum and has an initial term of 24 months and included a 2.0% origination fee, with completion and repayment supported by a corporate guaranty. In connection with the loan, the Company holds a right of first offer and right of first refusal with respect to a sale of the property, which are subject to the pre-leased tenant’s corresponding rights.
On July 28, 2026, the Company originated an approximately $2.2 million mezzanine loan secured by interests in an entity that owns an under-development medical facility in Daleville, Virginia. The medical facility is a two-story, approximately 40,000 square foot freestanding emergency department and medical office building that is 100% pre-leased to an investment-grade regional healthcare system under a 15-year lease. The loan bears interest at 12% per annum, has an initial term of 24-month and included a 2.0% origination fee, with completion and repayment supported by a corporate guaranty. In connection with the loan, the Company holds a right of first offer and right of first refusal with respect to a sale of the property, which are subject to the pre-leased tenant’s corresponding rights.
2026 Disposition Activity
On June 29, 2026, the Company disposed of certain properties in connection with its investment activity, including the sale of seven IRFs to the IRF Joint Venture described above under “Joint Ventures.”
Contracts to Purchase Seniors Housing Communities
The Landing Alexandria
On May 1, 2026, the Company entered into a purchase agreement with affiliates of Silverstone Senior Living (“SSL”) to acquire the Landing Alexandria (the “Landing”), a 163-home, luxury seniors housing community located in Alexandria, Virginia for a purchase price of approximately $130 million. The Landing offers independent living, assisted living and memory care. The Company intends to operate the community as a seniors housing operating property (“SHOP”) and to engage an affiliate of Greystone as a third-party manager to manage day-to-day operations. Under this structure, the Company will own the real estate and participate directly in the operating results of the property, including revenues and operating expenses, rather than receiving fixed lease payments from a third-party tenant. It is anticipated that this acquisition will close in the second quarter of 2026. The acquisition is subject to customary closing conditions, including, among other things, the completion of due diligence, licenses and approvals (if any), and other customary conditions. We cannot assure you that the acquisition will be completed on the anticipated terms or timetable, or at all.
The Riviera at Alexandria
On May 1, 2026, the Company entered into a purchase agreement with affiliates of SSL to acquire the Riviera at Alexandria (the “Riviera”), a 129-home, luxury independent living community located in Alexandria, Virginia for a purchase price of approximately $119 million. The Company intends to operate the community as a SHOP and to engage an affiliate of Greystone as a third-party manager to manage day-to-day operations. Under this structure, the Company will own the real estate and participate directly in the operating results of the property, including revenues and operating expenses, rather than receiving fixed lease payments from a third-party tenant. It is anticipated that this acquisition will close in the second quarter of 2026. The acquisition is subject to customary closing conditions, including, among other things, the completion of due diligence, licenses and approvals (if any), and other customary conditions. We cannot assure you that the acquisition will be completed on the anticipated terms or timetable, or at all.
The Pinnacle North Bethesda
On May 6, 2026, the Company entered into a purchase agreement to acquire the Pinnacle North Bethesda (the “Pinnacle”), a 175-home, luxury seniors housing community with ground floor retail located in North Bethesda, Maryland for a purchase price of approximately $176 million. The Pinnacle offers independent living, assisted living, and memory care housing. The Company intends to operate the community as a SHOP and to engage an affiliate of Greystone as a third-party manager to manage day-to-day operations. Under this structure, the Company will own the real estate and participate directly in the operating results of the property, including revenues and operating expenses, rather than receiving fixed lease payments from a third-party tenant. It is anticipated that this acquisition will close in the fourth quarter of 2026. The acquisition is subject to customary closing conditions, including, among other things, the completion of due diligence, licenses and approvals (if any), and other customary conditions We cannot assure you that the acquisition will be completed on the anticipated terms or timetable, or at all.
$100 Million Strategic Convertible Perpetual Preferred Equity Investment
On May 6, 2026 the Company entered into an agreement (the “Investment Agreement”) providing for an up to $100 million delayed-draw convertible perpetual preferred equity investment led by Maewyn Capital Partners (“Maewyn”), pursuant to which the Company may sell a total of $100 million of Series C convertible perpetual preferred stock (the “Series C Preferred Stock”), with a liquidation preference of $100 per share, either in full or in multiple tranches within six months from the date of the Investment Agreement. Dividends on the Series C Preferred Stock will accrue at a rate of 6.0% per year and will be payable quarterly in cash. If the Series C Preferred Stock remains outstanding beyond the fourth anniversary of the final draw under the Investment Agreement, the dividend rate will increase by 2.0% annually, up to a maximum of 12.0%. Holders of the Series C Preferred Stock will have the option to convert their shares into shares of the Company’s common stock at any time at the then-effective conversion rate (the “Conversion Rate”). The Conversion Rate of the Series C Preferred Stock will initially be set at 2.32558 shares of common stock, based on an implied conversion price of $43.00 per share of common stock. Three years after the final draw, the Company has the option to convert the Series C Preferred Stock to common stock if the volume-weighted average price of its common stock exceeds 120.0% of the conversion price for 45 consecutive trading days.
The Company may redeem the Series C Convertible Preferred Stock at par at any time, after the fourth anniversary of the final draw under the Investment Agreement. If the Series C Convertible Preferred Stock is redeemed, the Company will issue a warrant (each, a “Warrant”) to each holder of shares of Series C Preferred Stock that is redeemed. Each Warrant will represent a holder’s right to purchase, at an exercise price equal to the conversion price for the Series C Preferred Stock as of the business day before the applicable redemption date, a number of shares of common stock equal to the aggregate liquidation preference of the shares of Series C Preferred Stock of such holder to be redeemed divided by the conversion price of the Series C Preferred Stock as of the business day before the applicable redemption date. Each Warrant will be exercisable by the holder thereof, in whole or in part, at any time, or from time to time, prior to the fifth anniversary of the issuance of such Warrant.
Additionally, so long as Maewyn or its affiliates beneficially own at least 5.0% of the Company’s common stock on a fully-diluted basis, Maewyn will have the right to nominate one designee to be appointed as a member of the Board. The initial designee, Charles Fitzgerald, Managing Partner of Maewyn, will be appointed to the Company’s Board following the Company’s 2026 Annual Meeting of Stockholders on May 20, 2026.
Common Dividend Modification
On May 5, 2026, the Board declared a monthly common stock cash dividend of $0.16 per share for each of July, August and September of 2026, representing quarterly cash dividends totaling $0.48 per share. This compares to a monthly common stock cash dividend of $0.25 per share for April, May and June 2026, and represents an approximate 36% reduction. The Company is resizing its dividend to focus on retaining cash flow and to accelerate the Company’s acquisition strategy and accelerate the ramp of its SHOP portfolio.
Mezzanine Loan
On April 1, 2026, the Company closed a $3.0 million mezzanine loan secured by an under-development medical facility located in Fort Myers, Florida. The medical facility is an on-campus outpatient surgical facility that is 100% pre-leased to an investment-grade tenant under a 15-year lease with no termination rights. The loan bears interest at a rate of 12.0% per annum, has an initial term of 24 months, and represents approximately 10% of the total project cost. In connection with the loan, the Company holds a right of first offer and right of first refusal with respect to a sale of the property, which are subject to the pre-leased tenant’s corresponding rights.
Chapter 11 Reorganization Filing of White Rock Medical Center, LLC
On January 20, 2026, White Rock Medical Center LLC, filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code. At the time of its bankruptcy filing, White Rock operated two hospitals in Texas, including the White Rock Medical Center in Dallas, Texas, an acute-care hospital owned by the Company where White Rock is the sole tenant and has been operating the hospital since October 2023. There are 12 years remaining on this lease. According to the filed bankruptcy documents, the primary reason for the bankruptcy is a dispute with the former operator of the facility related to amounts due to the former operator. Accordingly White Rock plans to (i) restructure indebtedness related to its purchase of the hospital operations at the White Rock Medical Center and a related transition services agreement and (ii) sell its hospital operations to a third party, with the goal of stabilizing its operations and maximizing value to its stakeholders. As a means of assisting White Rock in its stabilization efforts, the Company has funded annual property tax obligations due under the lease and accepted reduced monthly payments. As of MayAugust 5,3, 2026, the Company has a receivable balance, net of security deposits, of approximately $1.5$1.7 million (exclusive of late fees and interest thereon). AlthoughOn weJuly expect10, 2026, White Rock tofiled affirmits Second Plan of Reorganization where it indicated that it plans on affirming our lease as part of its reorganization plan,plan. asAlthough ofWhite MayRock 5,indicated 2026,that noit reorganizationintends planon hasaffirming beenour filed with the courts andlease, there can be no assurance that White Rock will not change its plan to affirm its lease with us or that we will receive any amounts owed to us.
The preparation of financial statements in conformity with GAAP requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the CommissionSEC on March 2, 2026, for further information regarding the critical accounting policies that affect our more significant estimates and judgments used in the preparation of our condensed consolidated financial statements included in Part I, Item 1 of this Report.
Segment Results
Beginning June 1, 2026, we operate through two reportable segments: Healthcare Real Estate and SHOP. Healthcare Real Estate continues to represent the majority of our revenues and Segment NOI for the three and six months ended June 30, 2026. SHOP results reflect one month of operations from the Landing and the Riviera following their acquisition on June 1, 2026. SHOP Segment NOI was $0.3 million for both the three and six months ended June 30, 2026, reflecting the partial-period contribution from these communities. We expect SHOP to become a more significant component of our results as recently acquired communities stabilize and as we continue to pursue our seniors housing investment strategy.
Three Months Ended MarchJune 31,30, 2026 Compared to Three Months Ended MarchJune 31,30, 2025
Revenue
Total revenue for the three months ended MarchJune 31,30, 2026 was $38.1$39.7 million, compared to $34.6$38.0 million for the same period in 2025, representing an increase of $3.5$1.7 million. The increase was primarily driven by rental$1.8 revenue from properties acquired after March 31, 2025, as well as the recognitionmillion of aresident fullfees threeand monthsservices of rental revenue in 2026 from acquisitions completedrecognized during the threeone-month monthsperiod endedthat Marchwe 31,owned 2025.the Landing and the Riviera. These increases, together with growth in our existing portfolio,increases were partially offset by the impact of dispositions completed during the2026 sameand period.2025. Within thattotal increase,revenue, $6.3$5.6 million in revenue was recognized from net lease expense recoveries during the three months ended MarchJune 31,30, 2026, compared to $5.2$5.4 million for the same period in 2025.
Expenses
General and administrative expenses for the three months ended MarchJune 31,30, 2026 were $5.1$5.2 million, compared to $3.6$6.0 million for the same period in 2025, ana increasedecrease of $1.5$0.8 million. The increasedecrease was primarily driven by ana increasedecrease in professional fees of $0.4 million, non-cash LTIP compensation expense of $1.1 million, other compensation and benefits of $0.2$0.3 million, and general corporate expenses of $0.2$0.1 million.
Operating expenses for the three months ended MarchJune 31,30, 2026 were $9.3$10.0 million, compared to $7.6$8.2 million for the same period in 2025, an increase of $1.7$1.8 million. The increase was primarily attributable to portfolio$1.6 growth, including operating expenses from facilities acquired after March 31, 2025 and the inclusion of a full three monthsmillion of operating expenses inrelated 2026to the Landing and the Riviera for acquisitionsthe completedone-month period that we owned these properties during the three months ended MarchJune 31,30, 2025.2026. Operating expenses in the existing portfolio also increased,increased by $0.4 million, reflecting higher property‑level costs year over year.year-over-year. These increases were partially offset by the impact of dispositions completed during the2026 sameand period.2025. Included in these amounts were $6.3$5.6 million of recoverable property operating expenses incurred during the three months ended MarchJune 31,30, 2026, compared to $5.2$5.4 million for the same period in 2025.
Depreciation expense for the three months ended MarchJune 31,30, 2026 was $11.1$11.4 million, compared to $10.3$11.3 million for the same period in 2025, an increase of $0.8$0.1 million. The increase was primarily driven by properties acquired after March 31, 2025, as well as the recognition of a full three months of depreciation expense inour 2026 from acquisitions completed during the three months ended March 31, 2025,acquisitions, partially offset by the impact of dispositions completed during that2026 sameand period.2025.
Amortization expense for the three months ended MarchJune 31,30, 2026 was $3.7$3.8 million, compared to $3.5$4.0 million for the same period in 2025, ana increasedecrease of $0.2 million. The increasedecrease was primarily driven by properties acquired after March 31, 2025, as well as the recognition of a full three months of amortization expense in 2026 from acquisitions completed during the three months ended March 31, 2025, partially offset by dispositions and decreases on the existing portfolio during that same period.
Interest expense for the three months ended MarchJune 31,30, 2026 was $7.2$8.8 million, compared to $7.2$8.0 million for the same period in 2025.2025, Whilean ratesincrease declinedof from$0.8 2025million. toThe 2026, the decrease in interest expenseincrease was partially offsetdriven by increaseshigher dueinterest rates resulting from the expiration in April 2026 of the prior interest rate swaps on our Term Loan A and the replacement of those swaps with new interest rate swaps on the Term Loan A tranches that fix the SOFR component of the applicable interest rate at higher rates than the prior swaps. The increase was also partially attributable to higher average borrowings during the three months ended MarchJune 31,30, 2026,2026 compared to the same period in 2025.
The weighted average interest rate of our debt for the three months ended MarchJune 31,30, 2026 was 3.72%4.32% compared to 3.83%4.03% for the same period in 2025. Additionally, the weighted average interest rate and term of our debt was 3.58%4.56% and 3.93.6 years, respectively, at MarchJune 31,30, 2026, compared to 3.84%4.09% and 1.81.6 years, respectively, at MarchJune 31,30, 2025.
Income before other income (expense) for the three months ended MarchJune 31,30, 2026 was $1.7$0.4 million, compared to $2.4$0.4 million for the same period in 2025, a decrease of $0.7 million.2025.
During the three months ended MarchJune 31,30, 2026, we hadrecognized noa propertygain dispositions.on sale of investment properties of $71.9 million related to properties sold in connection with the establishment of the IRF Joint Venture. During the three months ended MarchJune 31,30, 2025, we completed twoone dispositionsdisposition resultingrecognizing in an aggregatea gain on sale of $1.4investment properties of $0.2 million.
Equity Loss from Unconsolidated Joint Ventures for the three months ended MarchJune 31,30, 2026 was $11$10 thousand, compared to $40$50 thousand for the same period in 2025, a decrease of $29$40 thousand.
XRN insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 16 Form 4 filings (12 insiders, 8 trade dates, 89,939 shares, about $3.2M) and open-market sales in 0 filings. Net open-market shares: 89,939 (purchases minus sales); net value about $3.2M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Whitlock Matthew Fitzsimmons |
Open-market purchase | 500 | $36.38 | $18.2K |
| 2026-08-14 | Whitlock Matthew Fitzsimmons |
Open-market purchase | 500 | $37.21 | $18.6K |
| 2026-08-12 | Roseth Aaron Robert |
Open-market purchase | 13,500 | $36.73 | $495.9K |
| 2026-08-11 | Decker Mark Okey Jr |
Open-market purchase | 6,875 | $35.92 | $246.9K |
| 2026-08-11 | Decker Mark Okey Jr |
Open-market purchase | 550 | $36.00 | $19.8K |
| 2026-08-11 | Fitzgerald Charles |
Open-market purchase | 14,000 | $35.78 | $500.9K |
| 2026-08-10 | Decker Mark Okey Jr |
Open-market purchase | 8,000 | $35.88 | $287.0K |
| 2026-08-10 | Fitzgerald Charles |
Open-market purchase | 27,600 | $35.94 | $991.9K |
| 2026-05-14 | Cypher Matthew |
Open-market purchase | 1,420 | $35.12 | $49.9K |
| 2026-05-12 | Wittman Lori |
Open-market purchase | 2,940 | $33.85 | $99.5K |
| 2026-05-12 | Marston Ronald |
Open-market purchase | 189 | $34.05 | $6.4K |
| 2026-05-12 | Marston Ronald |
Open-market purchase | 300 | $34.14 | $10.2K |
| 2026-05-12 | Marston Ronald |
Open-market purchase | 1,011 | $34.06 | $34.4K |
| 2026-05-12 | Barber Jamie Allen |
Open-market purchase | 1,481 | $33.50 | $49.6K |
| 2026-05-12 | Holley Danica |
Open-market purchase | 1,490 | $33.99 | $50.6K |
| 2026-05-12 | Decker Mark Okey Jr |
Open-market purchase | 1,000 | $33.74 | $33.7K |
| 2026-05-12 | Decker Mark Okey Jr |
Open-market purchase | 4,000 | $33.99 | $136.0K |
| 2026-05-11 | Kiernan Robert J |
Open-market purchase | 3,000 | $33.49 | $100.5K |
| 2026-05-11 | Crowley Paula |
Open-market purchase | 1,000 | $34.00 | $34.0K |
| 2026-05-11 | Cole Henry |
Open-market purchase | 575 | $34.32 | $19.7K |
| 2026-05-11 | Cole Henry |
Open-market purchase | 8 | $33.36 | $267 |
Well-known investors holding XRN (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 57,137 | $2.1M | 0.0% | Reduced 39% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 48,233 | $1.8M | 0.0% | Added 111% |
| AQR Capital Management (Cliff Asness) | 2026-06-30 | 44,097 | $1.7M | 0.0% | Added 258% |
| Millennium Management (Israel Englander) | 2026-06-30 | 22,148 | $732.7K | — | Sold out |
| D. E. Shaw & Co. | 2026-06-30 | 16,295 | $611.4K | 0.0% | New position |
| Renaissance Technologies | 2026-06-30 | 14,297 | $536.4K | 0.0% | Reduced 23% |